Tag: personalized medicine
Eric Rosenthal Reports: Why Academia Wasn’t Ready to Build Big Data...
Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion.
Roche...
AACR 2016: Companion and Complementary Diagnostics
Over the last decade, Targeted Therapies, Personalized and Precision Medicine have become part of our vocabulary, representing a new way of thinking in how...
European Commission Approves Label Variation for Brentuximab Vedotin
The European Commission (EC) has, earlier this week, approved a Type II variation for brentuximab vedotin (Adcetris®; Takeda/Seattle Genetics) to include data on the...
Kairos and Zymeworks Bring Together Complementary Technologies for the Development of...
Zymeworks, a privately held biotherapeutics company developing best-in-class Azymetric™ bi-specific antibodies, multi-specific antibodies and antibody drug conjugates for the treatment of cancer, and Kairos Therapeutics,...
How Personalization Will Improve Healthcare
While healthcare reform has many challenges, there are some very positive things happening behind the scenes. One of them is how we diagnose and...
